Advanced Therapy Medicinal Products (ATMPs), also known as cell and gene therapies, are becoming increasingly common. However, they’re far more complex than “traditional” biotech products, with sophisticated requirements throughout their supply chains. This paper summarizes a webinar that AIM conducted in late 2022 on how companies can orchestrate successful supply chains for ATMPs.
To read more, please download this free white paper.
Thank you.Please check your email to download the white paper.